Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer
Adam C. Powell(HealthInsight), Amit Gupta(University of Washington), Erin M. Kren(HealthInsight), Laura E. Happe(Humana (United States)), James W. Long(Pennsylvania State University), Bryan A. Loy(Humana (United States)), Amin Mirhadi(Cedars-Sinai Medical Center)
Cited by 3
Related Papers
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
|Cancer Immunology Research|2019|313
Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist Device
|Journal of the American College of Cardiology|2014|243
Inhalation Toxicity and Lung Toxicokinetics of C60 Fullerene Nanoparticles and Microparticles
|Toxicological Sciences|2007|201
Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles
|Journal of Biological Chemistry|2011|188